Rain Enhancement Technologies Holdco Inc (RAIN) FinancialsRAINFinancialRain Enhancement Technologies Holdco Inc

Evaluating the bottom line, Rain Enhancement Technologies Holdco Inc maintains a gross margin of N/A. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at -47451.14%, while the net margin is -48637.00%. These profitability ratios, combined with a Return on Equity (ROE) of N/A, provide a clear picture of how effectively RAIN converts its operational activities into shareholder value.

In the context of the broader market, RAIN competes directly with industry leaders such as NVNI and ICMB. With a market capitalization of $9.46M, it holds a significant position in the sector. When comparing efficiency, RAIN's gross margin of N/A stands against NVNI's 64.97% and ICMB's 96.75%. Such benchmarking helps identify whether Rain Enhancement Technologies Holdco Inc is trading at a premium or discount relative to its financial performance.

Rain Oncology has not generated any revenue for several quarters, with total revenue reported as 0.00 USD in Q4 2024 through Q2 2026, and a net income loss of -3,246,657 USD in Q2 2026.